Uncertainties related to the assignment of a toxic equivalency factor for 1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin

Regulatory Toxicology and Pharmacology

Volumn 44, Issue 3, 2006, Pages 219-225

  Sutter, Carrie Hayes ^a   Rahman, Mostafizur ^a   Sutter, Thomas R ^a  

^a UNIVERSITY OF MEMPHIS   (United States)

Author keywords

Cancer; Dioxin; OCDD; TCDD; TEF

Indexed keywords

CYTOCHROME P450 1A2; DIOXIN; FAT; POLYCHLORINATED DIBENZODIOXIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CLASSIFICATION; CANCER RISK; CARCINOGENICITY; COMPARATIVE STUDY; HEALTH HAZARD; HUMAN; HUMAN CELL; LIVER; LIVER CELL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RODENT; SENSITIVITY ANALYSIS; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; TOXICITY; TOXICOLOGY;

ANIMALS; CARCINOGENS; CYTOCHROME P-450 CYP1A2; ENVIRONMENTAL POLLUTANTS; HUMANS; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RATS; RISK ASSESSMENT; STRUCTURE-ACTIVITY RELATIONSHIP; TETRACHLORODIBENZODIOXIN;

RODENTIA;

EID: 33645879511     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2005.12.005     Document Type: Article

References (36)

1. Agency for Toxic Substances and Disease Registry, 1994 Draft. US Department of Health and Human Services. Toxicological Profile for Polycyclic Aromatic Hydrocarbons (PAHs).
2. 50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
3. Couture L.A., Elwell M.R., and Birnbaum L. Dioxin-like effects observed in male rats following exposure to octachlorodibenzo-p-dioxin (OCDD) during a 13-week study. Toxicol. Appl. Pharmacol. 93 (1988) 31-46
4. Eadon G., Kaminsky L., Silkworth J., Aldous K., Hilker D., O'Keefe P., Smith R., Gierthy J., Hawley J., Kim N., and DeCaprio A. Calculation of 2,3,7,8-TCDD equivalent concentrations of complex environmental contaminant mixtures. Environ. Health Perspect. 70 (1986) 221-227
5. Goodman, and Gilman. In: Gilman, Rall, Nies, and Taylor (Eds). The Pharmacologic Basis of Therapeutics. eighth ed. (1990), Pergamon Press, New York
6. Harper P.A., Golas C.L., and Okey A.B. Characterization of the Ah receptor and aryl hydrocarbon hydroxylase induction be 2,3,7,8,-tetrachlorodibenzo-p-dioxin and benz(a)anthracene in the human A431 squamous cell carcinoma line. Cancer Res. 48 (1988) 2388-2395
7. Henry E.C., Kende A.S., Rucci G., Totleben M.J., Willey J.J., Deringer S.D., Pollenz R.S., Jones J.P., and Gasiewicz T.A. Flavone antagonists bind competitively with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation. Mol. Pharmacol. 55 (1999) 716-725
8. Kociba R.J., Keyes D.G., Beyer J.E., Carreon R.M., Wade C.E., Dittenber D.A., Kalnins R.P., Frauson L.E., Park C.N., Barnard S.D., Hummel R.A., and Humiston C.G. Results of a two-year toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46 (1978) 279-303
9. Korner W., Golor G., Schulz T., Wiesmuller T., Hagenmaier H., and Neubert D. Tissue concentrations and induction of a hepatic monooxygenase in male Wistar rats after repeated doses of defined polychlorinated dibenxo-p-dioxin and dibenzofurans (PCDDs and PCDFs) mixtures. Arch. Toxicol. 75 (2002) 653-664
10. Lipp H.-P., Schrenk D., Wiesmuller T., Hagenmaier H., and Bock K.W. Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins (PCDDs) and their constituents in human HepG2 cells. Arch. Toxicol. 66 (1992) 220-223
11. Lucier G.W. Humans are a sensitive species to some of the biochemical effects of structural analogs of dioxin. Environ. Toxicol. Chem. 10 (1991) 727-735
12. Maronpot R.R., Foley J.F., Takahashi K., Goldsworthy T., Clark G., Tritscher A., Portier C., and Lucier G. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histological, biochemical, and cell proliferation endpoints. Environ. Health Perspect. 101 (1993) 634-642
13. Miller D.M., Aust A.E., Voorman R., and Aust S. Inhibition of 2-aminofluorene mutagenesis in bacteria by inducers of cytochrome P450d. Carcinogenesis 9 (1988) 327-329
14. Moriguchi T., Motohashi H., Hosoya T., Nakajima O., Takahashi S., Ohsako S., Aoki Y., Nishimura N., Tohyama C., Fujii-Kuriyama Y., and Yamamoto M. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc. Natl. Acad. Sci. USA 100 (2003) 5652-5657
15. Osawa Y., Higashiyama T., Shimizu Y., and Yarborough C. Multiple functions of aromatase and the active site structure; aromatase is the placental estrogen 2-hydroxylase. J. Steroid Biochem. Mol. Biol. 44 (1993) 469-480
16. Pohjanvirta R., Unkila M., Linden J., Tuomisto J.T., and Tuomisto J. Toxic equivalency factors do not predict the acute toxicities of dioxins in rats. Eur. J. Pharmacol. 293 (1995) 341-353
17. Poland A., and Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Toxicol. 22 (1982) 517-554
18. 125I]2-Iodo-3,7,8-trichlordibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification. Mol. Pharmacol. 36 (1989) 113-120
19. 125I]iodo-7,8-dibromodibenzo-p-dioxin as a probe to determine the relative ligand affinity of human versus mouse aryl hydrocarbon receptor in cultured cells. Mol. Pharmacol. 66 (2004) 129-136
20. Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations of toxic equivalency factors (TEFs). Crit. Rev. Toxicol. 21 (1990) 51-88
21. Staskal D.F., Diliberto J.J., Devito M.J., and Birnbaum L.S. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol. Sci. 84 (2005) 225-231
22. Schrenk D., Lipp H.-P., Wiesmuller T., Hagenmaier H., and Bock K.W. Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins: comparisons between defined mixtures and their constituents. Arch. Toxicol. 65 (1991) 114-118
23. Silkworth J.B., Koganti A., Illouz K., Possolo A., Zhao M., and Hamilton S.B. Comparison of TCDD and PCB CYP1A inductin sensitivies in fresh hepatocytes from human donors, Sprague-Dawley rats, and Rhesus monkeys and HepG2 cells. Toxicol. Sci. 87 (2005) 508-519
24. T.R. Sutter, C.W. Cody, J.A. Gastel, C.L. Hayes, L. Ying, N.J. Walker, H. Yin, 1995. Receptor mediated toxicity: the dioxin receptor as an example of biological complexity and experimental approaches. NATO ASI Series, vol. H93, pp. 21-35.
25. Tritscher A.M., Goldstein J.A., Portier C.J., McCoy Z., Clark G.C., and Lucier G.W. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res. 52 (1992) 3436-3442
26. US EPA, 2000. National Center for Environmental Assessment, Integrated Risk Information System (IRIS) database.
27. US EPA, March 2005. (EPA/630/P-03/001F). Guidelines for Carcinogen Risk Assessment. Risk Assessment Forum, Washington, DC.
28. US EPA NAS Review Draft, December 2003. Exposure to Human Health Reassessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and Related Compounds. National Center for Environmental Assessment, Office of Research and Development, US EPA, Washington, DC.
29. Van den Berg M., Birnbaum L., Bosveld A.T., Brunstrom B., Cook P., Feeley M., Giesy J.P., Hanberg A., Hasegawa R., Kennedy S.W., Kubiak T., Larsen J.C., van Leeuwen F.X., Liem A.K., Nolt C., Peterson R.E., Poellinger L., Safe S., Schrenk D., Tillitt D., Tysklind M., Younes M., Waern F., and Zacharewski T. Toxic Equivalency Factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect. 106 (1998) 775-792
30. van der Weiden M.E.J., de Vries L.P., Fase K., Celander M., Seinen W., and van den Berg M. Relative potencies of polychlorinated dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs) and biphenyls (PCBs), for cytochrome P450 1A induction in the mirror carp (Cyprinus carpio). Aquat. Toxicol. 29 (1994) 163-182
31. Voorman R., and Aust S.D. Specific binding of polyhalogenated aromatic hydrocarbon inducers of cytochrome P450d to the cytochrome and inhibition of its estradiol 2-hydroxylase activity. Toxicol. Appl. Pharmacol. 90 (1987) 69-78
32. Waller C.L., and McKinney J.D. Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization. Chem. Res. Toxicol. 8 (1995) 847-858
33. Wiebel F.J., Wegenke M., and Kiefer F. Bioassay for determining 2,3,7,8-tetrachlorodibenzo-p-dioxin equivalents (TEs) in human hepatoma HepG2 cells. Toxicol. Lett. 8 (1996) 335-338
34. Wermelinger, H., Poiger, H., Schlatter, C.H., 1990. Results of a 9-month feeding study with OCDD and OCDF in rats. In: Hutzinger, O., Fiedler. (Eds.) Organohalogen Compounds, vol. 1, pp. 221-224.
35. WHO, 1998. TEF database. Kindly provided by e-mail as an xls.zip file from Dr. F.X. Rolaf Van Leeuwen, European Centre for Environment and Health, Bilthoven Division, World Health Organization, Bilthoven, The Netherlands.
36. Zeiger M., Haag R., Hockel J., Schrenk D., and Schmitz H.-J. Inducing effects of dioxin-like polychlorinated biphenyls on CYP1A in the human hepatoblastoma cell line HepG2, the rat hepatoma cell line H4IIE, and rat primary hepatocytes: comparison of relative potencies. Toxicol. Sci. 63 (2001) 65-73